COST-EFFECTIVENESS OF DENOSUMAB IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS (PMO) WOMEN IN MEXICO AT HIGH RISK OF FRACTURES AND INTOLERANT TO ORAL BISPHOSPHONATES

被引：1

作者：

Arocho, R. ^{[1
]}

Rivera Hurtado, R. ^{[2
]}

Salinas Escudero, G. ^{[3
]}

机构：

[1] Amgen Inc, Barcelona, Spain

[2] Amgen Mexico, Mexico City, DF, Mexico

[3] Hosp Infantil Mexico Dr Federico Gomez, Secretaria Salud, Mexico City, DF, Mexico

来源：

关键词：

D O I：

10.1016/j.jval.2013.03.1141

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A225 / A225

页数：1